Cellular Origins

Enabling cell therapy manufacture at scale

Melbourn, United Kingdom · Founded 2022 · $40.0M raised

Headquarters
Melbourn
Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$40.0M
Last Round
$40.0M Series ADec 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Cellular Origins is enabling the manufacture of cell therapies at scale by combining robotics, AI, and deep bioprocess expertise. The company's flagship product, Constellation, is a mobile robotic ecosystem that fully automates cell therapy manufacturing processes — from clinical to commercial scale — while integrating the existing technologies and equipment that therapy developers already use. Based in Melbourn, UK and founded in 2022 as a TTP Company, Cellular Origins works with leading CDMOs and pharmaceutical partners including Johnson & Johnson to industrialize CAR-T and other cell therapy workflows, reducing labor by 16x and lowering cost of goods by 51%.

Summary

Cellular Origins is a Biotech company based in Melbourn, United Kingdom, founded in 2022. It has raised $40.0M in total across 1 round, most recently a $40.0M Series A round in Dec 2025. Investors include Johnson & Johnson Innovation, Highland Europe and NYBC Ventures.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ADec 2025
$40.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cellular Origins on Indexed.vc
<a href="https://indexed.vc/companies/cellular-origins"><img src="https://indexed.vc/api/badge/company/cellular-origins" alt="Cellular Origins on Indexed.vc" width="260" height="76" /></a>